Managing Resistant Nosocomial Infections: Bringing New Treatment Options to Light CME/CE
David L. Paterson, MD, PhD; Robert A. Weinstein, MD; Susan J. Rehm, MD
Disclosures

Release Date: December 29, 2005; Valid for credit through December 29, 2006


This CME activity is based on transcripts and slides of presentations as delivered by the faculty at the "Managing Resistant Nosocomial Infections: Bringing New Treatment Options to Light" symposium held at the San Francisco Marriott in San Francisco, CA on October 6, 2005.

Contents of This CME/CE Activity
This activity is offered in two formats. Please choose one of the versions:

    Slides and Audio Version
    (A multimedia presentation with synchronized audio, slides and transcript.)
    Note: Macromedia's Flash Player 5 plug-in is required to view the Flash version.
    Download the Macromedia Flash Player 5 plug-In:

    Get Flash 5

    --OR--

    Slides with transcript:

  1. The Evolution of Antimicrobial Resistance in the Hospital Setting: Unveiling the Patterns

    2. by David L. Paterson, MD, PhD
    Epidemiology of Antimicrobial Resistance
    Community-Acquired Infection: Will It Change Empiric Prescribing Patterns?
    Gram-Negative Bacilli: Resistance Patterns
    Community-Acquired Extended-Spectrum Beta-Lactamases
    Carbapenemase-Producing Klebsiella
    Treating Hospital-Acquired Panresistance

  2. Infection Control Measures: Meeting the Challenges of Compliance and Containment

    3. by Robert A. Weinstein, MD
    Nosocomial Pathogens and Reaching Safety Goals
    Hand Hygiene and Other Preventions
    Isolation, Contact Precautions, and the Environment
    Antibiotic Utilization and Effectiveness
    Device-Related Infections
    Improving Host Defenses

  3. What's on the Horizon? Advances in the Treatment of Infections Due to Resistant Healthcare-Associated Pathogens

    4. by Susan J. Rehm, MD
    Increasing Antimicrobial Resistance and Few New Drugs
    Current Antimicrobials: Activity and Resistance
    New Antimicrobials in the Pipeline: A Cephalosporin, a Carbapenem, a Quinolone
    New Antimicrobials in the Pipeline: Glycopeptides
    A New Antibiotic in a New Class of Antimicrobials: Tigecycline, a Glycylcycline
    Tigecycline Clinical Trial Results

Take this program with you!
Download this Web Conference as an MP3 and load it onto your iPod or other portable audio player for audio CME on-the-go.
audio MP3 Audio file David L. Paterson, MD, PhD
MP3 Audio file Robert A. Weinstein, MD
MP3 Audio file Susan J. Rehm, MD
(Right-click and select "Save Target As…" to download)
These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

 
Copyright © 2005 Bimark Center.
Wyeth
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME/CE Information
 
The Bimark Center
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Bimark Center for Medical Education (Bimark Center) and the National Foundation for Infectious Diseases (NFID). The Bimark Center is accredited by the ACCME to provide continuing medical education for physicians.

The Bimark Center designates this educational activity for a maximum of 2.0 Category 1 credit(s) toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Contact This Provider

The Bimark Center is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners (AANP), approved provider number 040710.

This activity has been granted 2 contact hours of continuing education by the AANP.

Contact This Provider

ACPE logoThe Bimark Center for Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (No. 799), and complies with the Criteria for Quality for continuing pharmacy education programming.

The ACPE number for this program is 799-000-05-065-H01. This program is acceptable for 2 hours (0.2 CEUs) of continuing education credit in states that recognize ACPE-accredited providers.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.